SanofiSanofiSanofi

Sanofi

No trades
See on Supercharts

Key facts today


Sanofi's Dupixent gained approval in Japan as the first biologic for chronic obstructive pulmonary disease (COPD) in adults, enhancing its global presence in over 45 countries.
Sanofi's CEO, Paul Hudson, met with Chinese President Xi Jinping in Beijing to announce a 1 billion euro ($1.1 billion) investment in an insulin production base.
Sanofi's stock rose by 1.5% in Friday trading, contributing to the overall performance of European equities in the US.
Analyze the impactAnalyze the impact
Market capitalization
‪134.75 B‬USD
2.40USD
‪6.01 B‬USD
‪44.44 B‬USD
‪2.45 B‬
Beta (1Y)
0.07

About SANOFI


CEO
Paul Hudson
Website
Headquarters
Paris
Founded
1994
FIGI
BBG000BBD5N1
Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
SANAU
SANOFI1%01APR25
Yield to maturity
26.62%
Maturity date
Apr 1, 2025
US801060AD6
SANOFI SA 18/28
Yield to maturity
4.45%
Maturity date
Jun 19, 2028
FR1332437
SANOFI 18/38 MTN
Yield to maturity
3.72%
Maturity date
Mar 21, 2038
FR1340985
SANOFI 19/34 MTN
Yield to maturity
3.25%
Maturity date
Mar 21, 2034
FR1332435
SANOFI 18/30 MTN
Yield to maturity
2.96%
Maturity date
Mar 21, 2030
FR1400Y1I
SANOFI 25/31 MTN
Yield to maturity
2.94%
Maturity date
Mar 11, 2031
FR1350511
SANOFI 20/30 MTN
Yield to maturity
2.94%
Maturity date
Apr 1, 2030
FR1340984
SANOFI 19/29 MTN
Yield to maturity
2.89%
Maturity date
Mar 21, 2029
FR1400Y1H
SANOFI 25/27 FLR MTN
Yield to maturity
2.85%
Maturity date
Mar 11, 2027
FR14009KQ
SANOFI 22/29 MTN
Yield to maturity
2.80%
Maturity date
Apr 6, 2029
FR1314400
SANOFI 16/28 MTN
Yield to maturity
2.57%
Maturity date
Apr 5, 2028

See all SNY bonds 


Check out other big names from the same industry as SNY.